Page 529 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

18 BISANTRENE 487

LITMAN T. et al., The multidrug-resistant phenotype associated with overexpression of
the new ABC hait-transporter, J. Cel/ Sei., 2000, 113, 2011-2021.
Van VEEN H.W. et al., Multidrug transport by ATP binding cassette transporters: a pro-
posed two-cylinder engine mechanism, Res. Microbiol., 2001, 152, 365-374.
EFFETS INDÉSIRABLES, PRÉCAUTIONS D'EMPLOI
FALKSON, G. et al., Hematological toxicity : experience with anthracyclines and anthra-
cenes, Exp. Hematol. (N. Y.), 1985, 13, 64-71.
BRON, D. et al., Quantitation of differential sensitivity of normal marrow myeloid proge-
nitor cells to anthracene derivatives, lnvest. New Drugs, 1986, 4, 11-16.
DORR R. et al., Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA
intercalating agents in vitro, Anti-Cancer Drugs, 1991, 2, 27-33.